Suppr超能文献

C-X-C 基序趋化因子配体 14 是肿瘤进展的独特多功能调节剂。

C-X-C Motif Chemokine Ligand 14 is a Unique Multifunctional Regulator of Tumor Progression.

机构信息

Oral Health Science Research Center, Graduate School of Kanagawa Dental University, Yokosuka 238-8580, Japan.

Department of Dentomaxillofacial Diagnosis and Treatment, Graduate School of Kanagawa Dental University, Yokosuka 238-8580, Japan.

出版信息

Int J Mol Sci. 2019 Apr 16;20(8):1872. doi: 10.3390/ijms20081872.

Abstract

Cancer is a leading cause of death and disease worldwide, with a tremendous financial impact. Thus, the development of cost-effective novel approaches for suppressing tumor growth and progression is essential. In an attempt to identify the mechanisms responsible for tumor suppression, we screened for molecules downregulated in a cancer progression model and found that the chemokine CXCL14, also called BRAK, was the most significantly downregulated. Increasing the production of CXCL14 protein by transfecting tumor cells with a CXCL14 expression vector and transplanting the cells into the back skin of immunodeficient mice suppressed tumor cell growth compared with that of parental tumor cells, suggesting that CXCL14 suppressed tumor growth in vivo. However, some studies have reported that over-expression of CXCL14, especially in stromal cells, stimulated the progression of tumor formation. Transgenic mice expressing 10-fold more CXCL14 protein than wild-type C57BL/6 mice showed reduced rates of chemical carcinogenesis, transplanted tumor growth, and metastasis without apparent side effects. CXCL14 also acts as an antimicrobial molecule. In this review, we highlight recent studies involving the identification and characterization of CXCL14 in cancer progression and discuss the reasons for the context-dependent effects of CXCL14 on tumor formation.

摘要

癌症是全球范围内导致死亡和疾病的主要原因,对经济造成了巨大的影响。因此,开发具有成本效益的新型方法来抑制肿瘤生长和进展至关重要。为了寻找抑制肿瘤的机制,我们筛选了癌症进展模型中下调的分子,发现趋化因子 CXCL14(也称为 BRAK)下调最为显著。通过转染肿瘤细胞表达 CXCL14 载体来增加 CXCL14 蛋白的产生,并将细胞移植到免疫缺陷小鼠的背部皮肤中,与亲本肿瘤细胞相比,抑制了肿瘤细胞的生长,表明 CXCL14 在体内抑制了肿瘤的生长。然而,一些研究报告称,CXCL14 的过表达,特别是在基质细胞中,刺激了肿瘤形成的进展。与野生型 C57BL/6 小鼠相比,表达 10 倍以上 CXCL14 蛋白的转基因小鼠显示出化学致癌作用、移植肿瘤生长和转移的速度降低,且没有明显的副作用。CXCL14 还作为一种抗菌分子发挥作用。在这篇综述中,我们强调了最近涉及 CXCL14 在癌症进展中的鉴定和特征描述的研究,并讨论了 CXCL14 对肿瘤形成的影响具有上下文依赖性的原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/723d/6514660/8ed45145df57/ijms-20-01872-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验